Immunohistochemical analysis of the DNA methyltransferase 3b expression is associated with significant improvements in the discrimination of ulcerative colitis-associated neoplastic lesions
Authors:
- 10 January 2013
- journal article
- research article
- Published by Springer Nature in Surgery Today
- Vol. 43 (11) , 1275-1280
Abstract
Making a clinicopathological diagnosis of dysplasia is crucial. We herein assess the significance of the DNA methyltransferase 3b (DNMT3b) expression as a diagnostic marker of ulcerative colitis (UC)-associated neoplasia.Keywords
This publication has 22 references indexed in Scilit:
- Immunohistochemical Analysis of REG Iα Expression in Ulcerative Colitis-Associated Neoplastic LesionsDigestion, 2011
- Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progressionGut, 2010
- Increased Expression of DNA Methyltransferase-1 in Non-Neoplastic Epithelium Helps Predict Colorectal Neoplasia Risk in Ulcerative ColitisDigestion, 2010
- DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal CancerClinical Cancer Research, 2009
- Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.2003
- An Essential Role for DNA Methyltransferase DNMT3B in Cancer Cell SurvivalJournal of Biological Chemistry, 2002
- The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut, 2001
- Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis‐related dysplasiaHistopathology, 2000
- Comparative analysis of histology, DNA content,p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitisInternational Journal of Cancer, 1998
- Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitisGastroenterology, 1994